Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease (ChagasCare)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by Evandro Chagas Institute of Clinical Research
Sponsor:
Collaborators:
Alejandro Marcel Hasslocher Moreno, MD MSc PhD student
Andrea Costa, MD PhD
Andrea Silvestre de Sousa, MD PhD
Luiz Henrique C. Sangenis, MD MSc PhD student
Marcelo Teixeira de Holanda, MD MSc PhD student
Mayara da Costa Chambela - MSc student
Pedro Emmanuel Alvarenga Americano do Brasil, MD PhD
Roberto Magalhães Saraiva, MD PhD
Sergio Salles Xavier, MD PhD
Information provided by (Responsible Party):
Gilberto Marcelo Sperandio da Silva, Evandro Chagas Institute of Clinical Research
ClinicalTrials.gov Identifier:
NCT01566617
First received: March 23, 2012
Last updated: February 23, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
No publications provided by Evandro Chagas Institute of Clinical Research

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):